Maverick recently received an audit by Australian Quarantine Inspection Services (AQIS) personnel with regard to attaining listing as an exporter of “intermediate Products” to the EU.

Listing is expected within the month, therefore easing constraints on exporting of processed biological device materials (Such as pericardium) to EU Countries.

PRESS RELEASES


Nikki’s story

From farm life to saving lives: How hard-working mum Nikki Allwell became a leader at our global operation Nikki Allwell is a true blue roll-up-your-sleeves, get-the-job-done kind of person. As a mother raising a young family while working on a farm, she had to be....

Dylan’s story

Real global impact: How Dylan Pope is shaping his incredible R&D career in the place he least expectedDylan Pope is a driven young chemist who pushes for better every day. Joining Maverick Bio as a Production Technician, he immediately identified the need for a...

James’ story

An unexpected career: James Gallagher found his great opportunity at #teammaverick - are you ready for yours?Born and bred in Dubbo, James Gallagher had never heard of Maverick Bio. The IT student had relocated to Canberra for his studies, but a reassessment of his...

Maverick Biomaterials Recommended for 13485 Certification

Maverick Biomaterials Pty Ltd, producer of cross linked GBR1 bovine pericardium in Australia and New Zealand, was audited on 23rd November by BSi for ISO 13485 Certification. This certification will optimise Maverick Biomaterials production and export of cross linked...